Skip to main content

PCI

Clinical Images
11/13/2023
A 70-year-old woman with diabetes presented with recurrent episodes of rest angina the previous month. She had undergone coronary angiography, which was suggestive of triple vessel disease.
A 70-year-old woman with diabetes presented with recurrent episodes of rest angina the previous month. She had undergone coronary angiography, which was suggestive of triple vessel disease.
A 70-year-old woman with...
11/13/2023
Journal of Invasive Cardiology
Original Contribution
08/15/2018
An obstacle to TRA is the risk of radial artery occlusion (RAO) after radial access in about 5%-10% of patients. We analyzed the safety and efficacy of getting vascular access after RAO by percutaneous transluminal angioplasty in cases of...
An obstacle to TRA is the risk of radial artery occlusion (RAO) after radial access in about 5%-10% of patients. We analyzed the safety and efficacy of getting vascular access after RAO by percutaneous transluminal angioplasty in cases of...
An obstacle to TRA is the risk...
08/15/2018
Journal of Invasive Cardiology
Original Contribution
06/15/2018
We evaluate the utility of the SYNTAX II score, which incorporates angiographic and clinical parameters, for risk stratification and prediction of 4-year mortality in 831 real-world patients.   
We evaluate the utility of the SYNTAX II score, which incorporates angiographic and clinical parameters, for risk stratification and prediction of 4-year mortality in 831 real-world patients.   
We evaluate the utility of...
06/15/2018
Journal of Invasive Cardiology
Clinical Images
08/29/2017
Two cases of pressure wire entrapment that may be related to wire design, with both instances occurring at the level of the pressure transducer.
Two cases of pressure wire entrapment that may be related to wire design, with both instances occurring at the level of the pressure transducer.
Two cases of pressure wire...
08/29/2017
Journal of Invasive Cardiology
07/31/2015
Dr Ford discusses the United States FDA’s “black box” warning on clopidogrel, and whether this designation was warranted based on the evidence at hand.
Dr Ford discusses the United States FDA’s “black box” warning on clopidogrel, and whether this designation was warranted based on the evidence at hand.
Dr Ford discusses the United...
07/31/2015
Journal of Invasive Cardiology